Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

LLY

Lilly(Eli) & Co

May 21 • 11:20AM ET

806.90

Dollar change +23.72
Percentage change 3.03	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VUG IVV IWF VHT QUAL IVW VV SCHG

Scroll to Statements

Index	S&P 500	P/E	120.84	EPS (ttm)	6.68	Insider Own	10.61%	Shs Outstand	949.38M	Perf Week	5.62%
Market Cap	766.88B	Forward P/E	42.18	EPS next Y	19.13	Insider Trans	-0.86%	Shs Float	849.57M	Perf Month	10.33%
Income	6.14B	PEG	2.13	EPS next Q	2.78	Inst Own	73.51%	Short Float	0.60%	Perf Quarter	8.18%
Sales	35.93B	P/S	21.34	EPS this Y	116.41%	Inst Trans	0.66%	Short Ratio	1.85	Perf Half Y	36.37%
Book/sh	13.48	P/B	59.86	EPS next Y	39.87%	ROA	10.48%	Short Interest	5.11M	Perf Year	82.40%
Cash/sh	2.72	P/C	296.52	EPS next 5Y	56.73%	ROE	51.15%	52W Range	419.80 - 800.78	Perf YTD	38.42%
Dividend Est.	5.30 (0.66%)	P/FCF	-	EPS past 5Y	13.74%	ROI	16.42%	52W High	0.76%	Beta	0.35
Dividend TTM	4.86 (0.60%)	Quick Ratio	1.03	Sales past 5Y	9.91%	Gross Margin	80.16%	52W Low	92.21%	ATR (14)	19.21
Dividend Ex-Date	May 15, 2024	Current Ratio	1.35	EPS Y/Y TTM	7.91%	Oper. Margin	31.58%	RSI (14)	63.00	Volatility	2.09% 2.23%
Employees	43000	Debt/Eq	2.05	Sales Y/Y TTM	29.76%	Profit Margin	17.08%	Recom	1.63	Target Price	869.47
Option/Short	Yes / Yes	LT Debt/Eq	1.92	EPS Q/Q	66.67%	Payout	77.91%	Rel Volume	2.46	Prev Close	783.18
Sales Surprise	-1.88%	EPS Surprise	4.64%	Sales Q/Q	25.98%	Earnings	Apr 30 BMO	Avg Volume	2.75M	Price	806.90
SMA20	6.13%	SMA50	6.08%	SMA200	24.58%	Trades		Volume	2,151,084	Change	3.03%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290
Feb-15-23	Downgrade	Societe Generale	Hold → Sell
Nov-18-22	Initiated	Credit Suisse	Outperform	$395
Sep-22-22	Upgrade	UBS	Neutral → Buy	$335 → $363
May-23-22	Initiated	SVB Leerink	Outperform	$341
Apr-06-22	Resumed	Morgan Stanley	Overweight	$265 → $364
Mar-10-22	Initiated	Daiwa Securities	Outperform	$286
Jan-21-22	Upgrade	DZ Bank	Hold → Buy	$291
Jan-03-22	Reiterated	Bernstein	Mkt Perform	$250 → $300

Show Previous Ratings

Today 10:41AM	If You'd Invested $10,000 in Eli Lilly Stock 5 Years Ago, Here's How Much You'd Have Today (Motley Fool)
09:10AM	Sector Update: Health Care Stocks Steady Premarket Tuesday (MT Newswires)
08:51AM	Eli Lilly and Company's Phase 3 Study of Mirikizumab to Treat Crohn's Disease Achieves 'Meaningful Improvements' (MT Newswires)
08:31AM	Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal (FierceBiotech.com)
08:00AM	More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved clinical remission at one year, including patients with previous biologic failure (PR Newswire)
07:20AM	Loading…
07:20AM	3 S&P 500 Stocks to Buy in May Before They Rocket Higher (InvestorPlace)
07:00AM	Eli Lilly Reportedly Gets Approval for Diabetes Drug Tirzepatide in China (MT Newswires)
03:50AM	Eli Lilly's diabetes drug tirzepatide gets approval in China (Reuters)
May-20-24 04:29PM	Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs (Investopedia)
04:07PM	Magnificent Seven? Just Two Members Clear This Bar (Investor's Business Daily)
03:16PM	HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections (InvestorPlace)
01:35PM	Sector Update: Health Care (MT Newswires)
10:26AM	Hims & Hers Health Adds Compounded Weight Loss Injections; Shares Rise (MT Newswires)
May-19-24 06:15AM	Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market? (Motley Fool)
May-18-24 09:31AM	Jim Cramer's 5 Latest Stock Picks in May 2024 (Insider Monkey)
03:02PM	Loading…
May-17-24 03:02PM	Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next? (InvestorPlace)
02:44PM	Rally Rockets: 3 Stocks Benefitting From the Market's Unstoppable Surge (InvestorPlace)
11:57AM	Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control (Zacks)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:24AM	Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk (Motley Fool)
06:31AM	Eli Lillys efsitora alfa shows promise in Phase III T2D trials (Clinical Trials Arena)
05:00AM	Weight loss pills, a Ozempic's big fan, and Merck's skin cancer drug: Pharma news roundup (Quartz)
May-16-24 05:23PM	Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia)
02:55PM	Eli Lilly says experimental weekly insulin works just as well as dailies (Quartz)
10:08AM	Roches New Weight-Loss Data Shows Lilly Isnt Unbeatable in Obesity (Barrons.com)
08:18AM	DarioHealth Corp. (NASDAQ:DRIO) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:13AM	The Dividend Investor's Playbook: 3 Stocks for Consistent Cash Flow in 2024 (InvestorPlace)
08:11AM	Lillys once-weekly insulin matches daily shots in late-stage tests (BioPharma Dive)
07:56AM	Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial (The Wall Street Journal)
07:55AM	Eli Lilly's Once-Weekly Insulin Efsitora Alfa Meets Primary Endpoint in Late-Stage Studies (MT Newswires)
07:15AM	Loading…
07:15AM	These 2 No-Brainer Growth Stocks Are Breaking New Ground (Motley Fool)
07:15AM	7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs (InvestorPlace)
07:03AM	UPDATE 2-Lilly's weekly insulin as effective as daily doses in studies (Reuters)
06:52AM	Lilly's weekly insulin succeeds in late-stage studies (Reuters)
06:45AM	With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin (PR Newswire)
06:15AM	Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade (InvestorPlace)
May-15-24 01:09PM	Wall Street Favorites: 3 Growth Stocks With Strong Buy Ratings for May 2024 (InvestorPlace)
12:03PM	Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound (Benzinga)
11:02AM	Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming? (Investor's Business Daily)
10:49AM	UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down (Reuters)
09:53AM	Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies (Zacks)
08:00AM	Alonzo Weems to Retire as Executive Vice President of Enterprise Risk Management and Chief Ethics and Compliance Officer (PR Newswire)
05:44AM	These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now (Motley Fool)
05:00AM	How to solve the weight loss drug shortage, according to a top Eli Lilly executive (Quartz)
May-14-24 05:46PM	Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs (Reuters)
04:22PM	Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs (The Wall Street Journal)
09:53AM	2 Top Pharma Stocks That Just Keep Getting Better and Better (Motley Fool)
08:59AM	Jim Cramer and Ken Fisher Love These 10 Stocks (Insider Monkey)
08:15AM	Argus Adjusts Price Target on Eli Lilly to $840 From $770 (MT Newswires)
07:30AM	Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540 (MT Newswires)
07:30AM	Is Eli Lilly's Latest Deal a Gamechanger? (Motley Fool)
06:30AM	Biotech Behemoths: 3 Giants Set to Dominate the Health Scene (InvestorPlace)
06:30AM	3 Magnificent Stocks That Are Passive Income Machines (Motley Fool)
May-13-24 07:52PM	Wegovy weight loss sustained for four years in trial, Novo Nordisk says (Reuters)
04:22PM	Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients (Benzinga)
03:43PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
07:00AM	The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory (InvestorPlace)
May-11-24 08:45AM	1 No-Brainer Growth Stock to Buy and Hold (Motley Fool)
03:50AM	Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. (Motley Fool)
May-10-24 05:09PM	Redwire Corporation (NYSE:RDW) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:45PM	Market Chatter: Cipla Open to Partner With Eli Lilly to Market Obesity Drugs in India (MT Newswires)
12:41PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:00AM	How A Top Fund Beats The Market By Owning Future Leaders (Investor's Business Daily)
06:31AM	Innovents mazdutide superior to Trulicity in Phase III T2D trial (Clinical Trials Arena)
06:30AM	3 Biotech Stocks to Sell in May Before They Crash & Burn (InvestorPlace)
05:20AM	UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says (Reuters)
May-09-24 04:45PM	Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
04:32PM	Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled (The Wall Street Journal)
01:46PM	Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:37PM	Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:41AM	Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
May-08-24 11:06AM	China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target (MT Newswires)
10:31AM	Viemed Healthcare, Inc. (NASDAQ:VMD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 02:38PM	What About Eli Lilly's Drug For Early Alzheimer's? FDA Panel To Discuss Next Month (Benzinga)
02:04PM	Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare (InvestorPlace)
11:29AM	13 Best Stocks That Will Always Grow (Insider Monkey)
11:02AM	Kevin OLearys Stock Portfolio: 10 Stock Picks for 2024 (Insider Monkey)
09:51AM	UPDATE 2-US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10 (Reuters)
09:38AM	US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10 (Reuters)
08:00AM	Mutual Funds Can't Get Enough Amazon, Broadcom (Investor's Business Daily)
07:19AM	FDA sets date for advisory meeting on Lillys closely watched Alzheimers drug (BioPharma Dive)
May-06-24 07:06PM	Why Eli Lilly Stock Jumped by 4% Today (Motley Fool)
02:30PM	3 Biotech Stocks to Double Your Money in the Next 24 Months (InvestorPlace)
11:32AM	Lilly Declares Second-Quarter 2024 Dividend (PR Newswire)
09:18AM	Lilly (LLY) Reliance on International Sales: What Investors Need to Know (Zacks)
09:00AM	Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
07:15AM	Investors Pile Into Amgen in Search of Next Obesity Drug Payout (Bloomberg)
04:10AM	2 Top Stocks That Could Make You Richer in 2024 (Motley Fool)
May-05-24 02:49PM	3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years (Motley Fool)
06:55AM	3 No-Brainer Stocks to Buy in May (Motley Fool)
May-04-24 08:30AM	Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making (Motley Fool)
06:45AM	Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market? (Motley Fool)
05:26AM	Eli Lilly Raised Its Outlook. Is the Stock a Buy Now? (Motley Fool)
May-03-24 05:33PM	Amazon Stock Is on a Roll. Heres Why Its on This Firms Best Ideas List. (Barrons.com)
05:07PM	Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market (Yahoo Finance)
02:53PM	Analyst unveils Amgen stock price target after weight-loss drug data (TheStreet)
02:39PM	3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030 (InvestorPlace)
12:37PM	Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:35AM	Weight-loss drug competition heats up. Is Wegovy in trouble? (Yahoo Finance Video)
10:51AM	Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying. (The Wall Street Journal)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zakrowski Donald A	SVP, Finance, & CAO	Mar 11 '24	Sale	753.60	750	565,200	7,880	Mar 11 04:27 PM
LILLY ENDOWMENT INC	10% Owner	Feb 16 '24	Sale	780.99	169,684	132,521,930	98,898,810	Feb 20 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 15 '24	Sale	760.46	50,316	38,263,417	99,068,494	Feb 16 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 09 '24	Sale	740.60	206,257	152,753,428	99,118,810	Feb 12 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 08 '24	Sale	740.06	8,743	6,470,336	99,325,067	Feb 09 04:05 PM
Van Naarden Jacob	EVP & Pres., Loxo@Lilly	Feb 01 '24	Option Exercise	0.00	3,618	0	15,463	Feb 02 04:22 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '24	Option Exercise	0.00	4,124	0	62,050	Feb 02 04:20 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '24	Option Exercise	0.00	9,941	0	115,262	Feb 02 04:25 PM
Norton Johna	EVP, Global Quality	Feb 01 '24	Option Exercise	0.00	1,268	0	31,382	Feb 02 04:24 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '24	Option Exercise	0.00	4,442	0	26,631	Feb 02 04:32 PM
Ricks David A	President, Chair, and CEO	Feb 01 '24	Option Exercise	0.00	29,611	0	455,054	Feb 02 04:28 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '24	Option Exercise	0.00	3,702	0	16,676	Feb 02 04:29 PM
Jonsson Patrik	EVP&Pres, LLY Dia&Obe, LLY USA	Feb 01 '24	Option Exercise	0.00	4,124	0	41,065	Feb 02 04:26 PM
LILLY ENDOWMENT INC	10% Owner	Jan 31 '24	Sale	648.07	78,573	50,920,924	99,333,810	Feb 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 30 '24	Sale	645.22	76,215	49,175,200	99,412,383	Jan 31 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 29 '24	Sale	645.07	54,032	34,854,422	99,488,598	Jan 30 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 16 '24	Sale	645.60	1,180	761,806	99,542,630	Jan 17 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 11 '24	Sale	634.13	12,344	7,827,686	99,543,810	Jan 12 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 10 '24	Sale	630.59	163,730	103,246,373	99,556,154	Jan 11 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Jan 09 '24	Sale	631.81	34,538	21,821,413	99,719,884	Jan 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 04 '24	Sale	630.28	14,388	9,068,445	99,754,422	Jan 05 02:15 PM
Zakrowski Donald A	SVP, Finance, & CAO	Dec 01 '23	Option Exercise	0.00	4,810	0	9,518	Dec 04 04:17 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 06 '23	Sale	571.10	670	382,637	4,708	Nov 06 04:25 PM
LILLY ENDOWMENT INC	10% Owner	Oct 11 '23	Sale	605.44	215,000	130,169,879	99,768,810	Oct 12 04:00 PM
Weems Alonzo	EVP, ERM & CECO	Sep 12 '23	Sale	590.98	1,148	678,445	7,760	Sep 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Sep 07 '23	Sale	571.41	210,000	119,995,275	99,983,810	Sep 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 31 '23	Sale	554.81	46,541	25,821,607	100,193,810	Sep 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 30 '23	Sale	555.32	6,181	3,432,417	100,240,351	Aug 31 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 29 '23	Sale	554.10	28,747	15,928,697	100,246,532	Aug 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 28 '23	Sale	554.12	37,660	20,868,163	100,275,279	Aug 29 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 25 '23	Sale	554.38	63,572	35,243,238	100,312,939	Aug 28 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 24 '23	Sale	554.74	20,992	11,645,029	100,376,511	Aug 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 23 '23	Sale	555.69	1,307	726,284	100,397,503	Aug 24 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 21 '23	Sale	546.51	600	327,906	5,378	Aug 22 04:34 PM
LILLY ENDOWMENT INC	10% Owner	Aug 15 '23	Sale	543.72	50,222	27,306,747	100,398,810	Aug 16 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 14 '23	Sale	539.08	164,778	88,829,243	100,449,032	Aug 15 04:00 PM
ELI LILLY & Co	10% Owner	Aug 11 '23	Buy	14.92	1,718,493	25,639,916	100	Aug 14 04:30 PM
LILLY ENDOWMENT INC	10% Owner	Aug 11 '23	Sale	528.50	83,039	43,886,430	100,613,810	Aug 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 10 '23	Sale	528.13	3,000	1,584,405	100,696,849	Aug 11 03:50 PM
LILLY ENDOWMENT INC	10% Owner	Aug 09 '23	Sale	528.83	123,961	65,554,314	100,699,849	Aug 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Aug 08 '23	Sale	523.74	204,409	107,056,405	100,823,810	Aug 09 05:10 PM
LILLY ENDOWMENT INC	10% Owner	Jul 21 '23	Sale	466.62	591	275,773	101,028,219	Jul 24 03:55 PM
LILLY ENDOWMENT INC	10% Owner	Jun 30 '23	Sale	467.60	164,125	76,744,390	101,028,810	Jul 03 12:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 29 '23	Sale	465.08	44,115	20,517,137	101,192,935	Jun 30 03:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '23	Sale	465.41	11,760	5,473,168	101,237,050	Jun 30 09:06 AM
LILLY ENDOWMENT INC	10% Owner	Jun 22 '23	Sale	459.28	107,022	49,153,574	101,248,810	Jun 23 11:27 AM
LILLY ENDOWMENT INC	10% Owner	Jun 21 '23	Sale	454.13	31,454	14,284,313	101,355,832	Jun 22 01:06 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '23	Sale	454.08	34,156	15,509,556	101,387,286	Jun 21 03:13 PM
LILLY ENDOWMENT INC	10% Owner	Jun 16 '23	Sale	455.50	25,015	11,394,292	101,421,442	Jun 20 01:26 PM
LILLY ENDOWMENT INC	10% Owner	Jun 15 '23	Sale	454.15	27,353	12,422,248	101,446,457	Jun 16 03:58 PM
Norton Johna	EVP, Global Quality	Jun 15 '23	Sale	448.00	1,647	737,856	30,114	Jun 15 04:21 PM
Norton Johna	EVP, Global Quality	Jun 14 '23	Sale	444.29	1,647	731,746	31,761	Jun 15 04:21 PM
Rau Diogo	EVP & CIDO	Jun 01 '23	Option Exercise	0.00	6,300	0	10,694	Jun 02 04:44 PM
Jonsson Patrik	EVP&Pres, LLY Imm, LLY USA&CCO	Jun 01 '23	Sale	429.46	6,000	2,576,760	36,941	Jun 02 04:29 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience